Open Access
Literature Review
Issue
J Oral Med Oral Surg
Volume 27, Number 3, 2021
Article Number 39
Number of page(s) 9
DOI https://doi.org/10.1051/mbcb/2021013
Published online 16 July 2021
  1. Kaczor-Urbanowicz KE, Martin Carreras-Presas C, Aro K, Tu M, Garcia-Godoy F, Wong DT. Saliva diagnostics − current views and directions. Exp Biol Med (Maywood) 2017;242:459–472. [CrossRef] [Google Scholar]
  2. Zhang C-Z, Cheng X-Q, Li J-Y, Zhang P, Yi P, Xu X, et al. Saliva in the diagnosis of diseases. Int J Oral Sci 29 2016;8:133–137. [CrossRef] [Google Scholar]
  3. Wang X, Kaczor-Urbanowicz KE, Wong DTW. Salivary biomarkers in cancer detection. Med Oncol 2017;34:7. [CrossRef] [Google Scholar]
  4. Jacob TV, Ramesh M, Murali S, Ramesh K, Sanjay PR, Abraham P. A non-invasive study to estimate and compare salivary sialic acid level as tumor marker in patients with pre-cancer and oral cancer. J Cancer Res Ther 2016;12:634–639. [CrossRef] [Google Scholar]
  5. Seyedmajidi S, Seyedmajidi M, Foroughi R, Zahedpasha A, Zolfaghari Saravi Z, Pourbagher R, et al. Comparison of Salivary and Serum Soluble CD44 Levels between Patients with Oral SCC and Healthy Controls. Asian Pac J Cancer Prev 2018;19:3059–3063. [CrossRef] [Google Scholar]
  6. Malhotra R, Urs AB, Chakravarti A, Kumar S, Gupta VK, Mahajan B. Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma. Tumour Biol 2016;37:9263–9271. [CrossRef] [Google Scholar]
  7. Zanotti L, Paderno A, Piazza C, Pagan E, Bignotti E, Romani C, et al. Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer. Laryngoscope 2017;127:E408– E4014. [CrossRef] [Google Scholar]
  8. Patel S, Metgud R. Estimation of salivary lactate dehydrogenase in oral leukoplakia and oral squamous cell carcinoma: a biochemical study. J Cancer Res Ther 2015;11:119–123. [CrossRef] [Google Scholar]
  9. Babiuch K, Bednarczyk A, Gawlik K, Pawlica-Gosiewska D, Kęsek B, Darczuk D, et al. Evaluation of enzymatic and non-enzymatic antioxidant status and biomarkers of oxidative stress in saliva of patients with oral squamous cell carcinoma and oral leukoplakia: a pilot study. Acta Odontol Scand 2019;1–11. [Google Scholar]
  10. Duz MB, Karatas OF, Guzel E, Turgut NF, Yilmaz M, Creighton CJ, et al. Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study. Cell Oncol (Dordr) 2016;39:187–193. [CrossRef] [Google Scholar]
  11. Gonçalves AS, Arantes DAC, Bernardes VF, Jaeger F, Silva JM, Silva TA, et al. Immunosuppressive mediators of oral squamous cell carcinoma in tumour samples and saliva. Hum Immunol 2015;76:52–58. [CrossRef] [Google Scholar]
  12. Bu J, Bu X, Liu B, Chen F, Chen P. Increased Expression of Tissue/Salivary Transgelin mRNA Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma (OSCC). Med Sci Monit 2015;21:2275–2281. [CrossRef] [Google Scholar]
  13. Ko H-H, Peng H-H, Cheng S-J, Kuo MY-P. Increased salivary AKR1B10 level: association with progression and poor prognosis of oral squamous cell carcinoma. Head Neck 2018;40:2642–2647. [CrossRef] [Google Scholar]
  14. Shetty SR, Babu SG, Rao PK, Kishor SK, Rao KA, Castelino R. Interdependence of antioxidants and micronutrients in oral cancer and potentially malignant oral disorders: a serum and saliva study. J Dent (Teheran) 2014;11:696–702. [Google Scholar]
  15. Kallalli BN, Rawson K, Muzammil null Singh A, Awati MA, Shivhare P. Lactate dehydrogenase as a biomarker in oral cancer and oral submucous fibrosis. J Oral Pathol Med 2016;45:687–690. [CrossRef] [Google Scholar]
  16. Rajaram S, Danasekaran BP, Venkatachalapathy R, Prashad KV, Rajaram S. N-acetylneuraminic acid: A scrutinizing tool in oral squamous cell carcinoma diagnosis. Dent Res J (Ispahan) 2017;14:267–271. [CrossRef] [Google Scholar]
  17. Arduino PG, Menegatti E, Cappello N, Martina E, Gardino N, Tanteri C, et al. Possible role for interleukins as biomarkers for mortality and recurrence in oral cancer. Int J Biol Markers 2015;30:e262–e266. [CrossRef] [Google Scholar]
  18. Gallo C, Ciavarella D, Santarelli A, Ranieri E, Colella G, Lo Muzio L. et al. Potential Salivary Proteomic Markers of Oral Squamous Cell Carcinoma. Cancer Genomics Proteomics 2016;13:55–61. [Google Scholar]
  19. Awasthi N. Role of salivary biomarkers in early detection of oral squamous cell carcinoma. Indian J Pathol Microbiol 2017;60:464–468. [CrossRef] [Google Scholar]
  20. Jou Y-J, Hua C-H, Lin C-D, Lai C-H, Huang S-H, Tsai M-H, et al. S100A8 as potential salivary biomarker of oral squamous cell carcinoma using nanoLC-MS/MS. Clin Chim Acta 2014;436:121–129. [CrossRef] [Google Scholar]
  21. Wu C-C, Chu H-W, Hsu C-W, Chang K-P, Liu H-P. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma. Proteomics 2015;15:3394–3404. [CrossRef] [Google Scholar]
  22. Kaur J, Politis C, Jacobs R. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action. Clin Oral Invest 2016;20:315–319. [CrossRef] [Google Scholar]
  23. Rajkumar K, Ramya R, Nandhini G, Rajashree P, Ramesh Kumar A, Nirmala Anandan S. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma. Oral Dis 2015;21:90–96. [CrossRef] [Google Scholar]
  24. Varun C, Dineshkumar T, Jayant VS, Rameshkumar A, Rajkumar K, Rajashree P, et al. Salivary Her2/neu levels in differentiation of oral premalignant disorders and oral squamous cell carcinomas. Asian Pac J Cancer Prev 2015;16:5773–5777. [CrossRef] [Google Scholar]
  25. Aziz S, Ahmed SS, Ali A, Khan FA, Zulfiqar G, Iqbal J, et al. Salivary immunosuppressive cytokines IL-10 and IL-13 are significantly elevated in oral squamous cell carcinoma patients. Cancer Invest 2015;33:318–328. [CrossRef] [Google Scholar]
  26. Panneer Selvam N, Sadaksharam J. Salivary interleukin-6 in the detection of oral cancer and precancer. Asia Pac J Clin Oncol 2015;11:236–241. [CrossRef] [Google Scholar]
  27. Liu C-J., Chen J-H., Hsia S-M., Liao C-C., Chang H-W., Shieh T-M., et al. Salivary LDOC1 is a gender-difference biomarker of oral squamous cell carcinoma. Peer J 2019;7:e6732. [CrossRef] [Google Scholar]
  28. Honarmand MH, Farhad-Mollashahi L, Nakhaee A, Nehi M. Salivary Levels of ErbB2 and CEA in oral squamous cell carcinoma patients. Asian Pac J Cancer Prev 2016;17:77–80. [CrossRef] [Google Scholar]
  29. Lohavanichbutr P, Zhang Y, Wang P, Gu H, Nagana Gowda GA, Djukovic D. et al. Salivary metabolite profiling distinguishes patients with oral cavity squamous cell carcinoma from normal controls. PLoS ONE 2018;13:e0204249. [CrossRef] [Google Scholar]
  30. Zahran F, Ghalwash D, Shaker O, Al-Johani K, Scully C. Salivary microRNAs in oral cancer. Oral Dis 2015;21:739–747. [CrossRef] [Google Scholar]
  31. Peisker A, Raschke G-F, Fahmy M-D, Guentsch A, Roshanghias K, Hennings J, et al. Salivary MMP-9 in the detection of oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2017;22:e270–e275. [Google Scholar]
  32. Michailidou E, Tzimagiorgis G, Chatzopoulou F, Vahtsevanos K, Antoniadis K, Kouidou S, et al. Salivary mRNA markers having the potential to detect oral squamous cell carcinoma segregated from oral leukoplakia with dysplasia. Cancer Epidemiol 2016;43:112–118. [CrossRef] [Google Scholar]
  33. Dadhich M, Prabhu V, Pai VR, D'Souza J, Harish S, Jose M. Serum and salivary sialic acid as a biomarker in oral potentially malignant disorders and oral cancer. Indian J Cancer 2014;51:214–218. [CrossRef] [Google Scholar]
  34. Achalli S, Madi M, Babu SG, Shetty SR, Kumari S, Bhat S. Sialic acid as a biomarker of oral potentially malignant disorders and oral cancer. Indian J Dent Res 2017;28:395–399. [CrossRef] [Google Scholar]
  35. Bhat S, Babu SG, Bhat SK, Castelino RL, Rao K, Madi M. Status of serum and salivary ascorbic acid in oral potentially malignant disorders and oral cancer. Indian J Med Paediatr Oncol 2017;38:306–310. [CrossRef] [Google Scholar]
  36. Shetty SR, Babu S, Kumari S, Shetty P, Hegde S, Karikal A. Status of trace elements in saliva of oral precancer and oral cancer patients. J Cancer Res Ther 2015;11:146–149. [CrossRef] [Google Scholar]
  37. Shah K, Patel S, Modi B, Shah F, Rawal R. Uncovering the potential of CD44v/SYNE1/miR34a axis in salivary fluids of oral cancer patients. J Oral Pathol Med 2018;47:345–352. [CrossRef] [Google Scholar]
  38. Arantes LMRB, de Carvalho AC, Melendez ME, Centrone CC, Góis-Filho JF, Toporcov TN, et al. Validation of methylation markers for diagnosis of oral cavity cancer. Eur J Cancer 2015;51:632–641. [CrossRef] [Google Scholar]
  39. Rajkumar K, Nandhini G, Ramya R, Rajashree P, Kumar AR, Anandan SN. Validation of the diagnostic utility of salivary interleukin 8 in the differentiation of potentially malignant oral lesions and oral squamous cell carcinoma in a region with high endemicity. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118:309–319. [CrossRef] [Google Scholar]
  40. Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther 2003;83:713–721. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.